With pricing and reimbursement considerations varying across different regions and healthcare systems, how do you ensure you have the optimal pricing strategy for your new pharmaceutical product? Are you fully informed of all the key factors and evidence requirements that are likely to influence successful market access for your product, and are you in a position to engage with payers and thought leaders to better understand their expectations and requirements?
At VISFO, we work quickly and collaboratively to bring you evidence-based recommendations to support your pricing and reimbursement strategy. A team of highly skilled health economists and market access consultants, we have a vast range of experience in delivering pricing strategies for clients, across multiple therapy areas and international markets, with our unique delivery portal designed to save you time and deliver a best-in-class service.
What we offer:
- Competitive landscaping
- ~Key learnings from competitor HTA pricing and reimbursement decisions
- ~An understanding of the evidence requirements needed to influence pricing and reimbursement decisions by HTA bodies
- Price landscaping
- ~An overview of the existing price landscape and potential price comparators to inform your pricing negotiations
- Stakeholder mapping
- ~Identification of payers and payer influencing key opinion leaders to inform engagement strategies